Trial · NCT07880470
Is Splinting After Ulnar Nerve Transposition Necessary?
NCT07880470, Not applicable, Not yet recruiting, University of Chicago
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Is Splinting After Ulnar Nerve Transposition Necessary? Trials, record NCT07880470. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07880470
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Is Splinting After Ulnar Nerve Transposition Necessary?
- NCT number
- NCT07880470
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 50 participants, estimated
- Lead sponsor
- University of Chicago
- Conditions
- Ulnar Nerve Transposition
- Interventions
- Stiff splint, No splint
- First posted
- 2026-10-19
- Last updated
- 2026-10-22
Source ClinicalTrials.gov
Registered outcomes5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Pittsburg Sleep Quality Index scores | 2 weeks, 6 weeks, 3 months, 6 months, 1 year | A survey that measures self reported sleep measures from a score of 0 to 21 and a score over 5 indicates sleep difficulties and poor sleep quality. |
| Secondary | Patient Reported Outcome Measures Information System (PROMIS) | 2 weeks, 6 weeks, 3 months, 6 months, 1 year | The PROMIS physical function instrument measures self reported capability for daily physical activities and is scored on standardized norm-based-T-score where higher scores indicate greater physical capacity and functioning. The PROMIS upper extremity instrument measures physical capability related to the hand, wrist, arm and shoulder. Responses are scored on a standardized norm-based-T-score where higher scores indicate better function. The PROMIS Pain Interference instrument measures daily pain levels and how they interrupt daily function. Responses are scored on a standardized norm-based-T-score where higher scores indicate greater pain interference. |
| Secondary | Average Patient-Reported Activity Level and Recovery Satisfaction | 2 weeks, 6 weeks, 3 months, 6 months, 1 year | Measures how quickly the participant returns to normal function in daily life and activity in weeks. Each questionnaire has two scales that are asked at each time point up to one year post-surgery. One asks about current activity level compared to pre-surgery on a scale of 1-10 with 1 being significantly less active and 10 being significantly more active. The other asks about satisfaction with the recovery process on a scale of 1-10 with 1 being very dissatisfied and 10 being very satisfied. |
| Secondary | Number of Patients with Post operative complications | 2 weeks, 6 weeks, 3 months, 6 months, 1 year | Includes rates of complications (wound dehiscence, recurrent nerve instability, hematoma formation) and reoperation measured by yes or no question at each timepoint. |
| Secondary | Change in Degrees of Elbow Range of Motion | 2 weeks, 6 weeks, 3 months, 6 months, 1 year | Measures the change in elbow flexion after the procedure compared to the pre-operative baseline. The evaluation is performed during the standard clinical exam with a continuous scale of 0-145 degrees with a larger degree of flexion indicating better recovery and joint mobility. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07880470
GET https://conductscience.org/api/trials/v1/NCT07880470/registered